Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GBNH declined for three days, in of 184 cases, the price declined further within the following month. The odds of a continued downward trend are .
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 41 cases where GBNH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
GBNH broke above its upper Bollinger Band on December 06, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GBNH entered a downward trend on December 05, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on December 06, 2023. You may want to consider a long position or call options on GBNH as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for GBNH just turned positive on December 06, 2023. Looking at past instances where GBNH's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
GBNH moved above its 50-day moving average on December 06, 2023 date and that indicates a change from a downward trend to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where GBNH advanced for three days, in of 137 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GBNH's P/B Ratio (16.722) is slightly higher than the industry average of (4.306). P/E Ratio (0.000) is within average values for comparable stocks, (72.109). GBNH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.357). GBNH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.023). P/S Ratio (0.114) is also within normal values, averaging (18.397).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GBNH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GBNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry MedicalNursingServices
A.I.dvisor tells us that GBNH and CCM have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GBNH and CCM's prices will move in lockstep.
Ticker / NAME | Correlation To GBNH | 1D Price Change % | ||
---|---|---|---|---|
GBNH | 100% | +44.14% | ||
CCM - GBNH | 22% Poorly correlated | +0.91% | ||
AMS - GBNH | 22% Poorly correlated | +1.03% | ||
BKD - GBNH | 21% Poorly correlated | -1.52% | ||
AMED - GBNH | 21% Poorly correlated | +0.30% | ||
RHE - GBNH | 13% Poorly correlated | -3.52% | ||
More |